Biodeal Pharmaceuticals Limited
PrivateLast Round
Growth Equity
Aug 10, 2026
Total Funding Raised
$57.2M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Biodeal Pharmaceuticals Limited operates in Healthcare & Life Sciences and is based in Noida. Its latest recorded funding round was a Growth Equity round in August 2026.
Biodeal Pharmaceuticals Limited is a pharmaceutical and nutraceutical company that provides contract development and manufacturing organization (CDMO) services for various medical supplies, including nasal sprays, inhalers, and sterile injectables.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biodeal Pharmaceuticals Limited Comparables
Compare Biodeal Pharmaceuticals Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tirupati Group | 85% | |
| Theon Pharmaceuticals Limited | 83% | |
| Windlas Biotech Limited | 81% |
For institutional investors. Book with your work email.
Biodeal Pharmaceuticals Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Aug 10, 2026 | ||||
| Convertible Debt | Apr 8, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biodeal Pharmaceuticals Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Piramal Alternatives | Convertible Debt |
| RMB Capitalworks | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
$44M round led by RMB Capitalworks
- Jun 18, 2026
Monthly visitors increased 35% MoM.
For institutional investors. Book with your work email.
Biodeal Pharmaceuticals Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biodeal Pharmaceuticals Limited's valuation, stock price, and market status.
Is Biodeal Pharmaceuticals Limited a public or private company?
Biodeal Pharmaceuticals Limited is a private company.
What is the current stock price of Biodeal Pharmaceuticals Limited?
Biodeal Pharmaceuticals Limited is a private company, so its shares have no public market price. Caplight tracks Biodeal Pharmaceuticals Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biodeal Pharmaceuticals Limited worth (valuation)?
Valuation information for Biodeal Pharmaceuticals Limited is not publicly available.
Can I buy Biodeal Pharmaceuticals Limited stock?
Biodeal Pharmaceuticals Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biodeal Pharmaceuticals Limited's last funding round?
Biodeal Pharmaceuticals Limited's most recent funding round was Growth Equity on August 10, 2026.
Who are the main investors in Biodeal Pharmaceuticals Limited?
Key investors in Biodeal Pharmaceuticals Limited include RMB Capitalworks.
Will Biodeal Pharmaceuticals Limited IPO soon?
No public IPO plans have been announced for Biodeal Pharmaceuticals Limited.
How can I track Biodeal Pharmaceuticals Limited secondary market activity?
Caplight tracks bids, offers, and trades in Biodeal Pharmaceuticals Limited's shares on secondary markets.